Write to authors to ask them to make this article freely available at NoL Archive
N-Acetylaspartate in the CNS: From Neurodiagnostics to Neurobiology
John R. Moffett,1,2 Brian Ross,3 Peethambaran Arun,1 Chikkathur N. Madhavarao,1 and M. A. A. Namboodiri1
1 Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Building C, 4301 Jones Bridge Rd., Bethesda, MD 20814, USA
3 Magnetic Resonance Unit, Huntington Medical Research Institutes, Pasadena, CA; Rudi Schulte Research Institute, Santa Barbara CA and NARSAD
2 Contact: J.R. Moffett, phone (301) 295-9357, fax (301) 295-3566, Email: jmoffett@usuhs.mil.
AbstractThe brain is unique among organs in many respects, including its mechanisms of lipid synthesis and energy production. The nervous system-specific metabolite N-acetylaspartate (NAA), which is synthesized from aspartate and acetyl-coenzyme A in neurons, appears to be a key link in these distinct biochemical features of CNS metabolism. During early postnatal CNS development, the expression of lipogenic enzymes in oligodendrocytes, including the NAA-degrading enzyme aspartoacylase (ASPA), is increased along with increased NAA production in neurons. NAA is transported from neurons to the cytoplasm of oligodendrocytes, where ASPA cleaves the acetate moiety for use in fatty acid and steroid synthesis. The fatty acids and steroids produced then go on to be used as building blocks for myelin lipid synthesis. Mutations in the gene for ASPA result in the fatal leukodystrophy Canavan disease, for which there is currently no effective treatment. Once postnatal myelination is completed, NAA may continue to be involved in myelin lipid turnover in adults, but it also appears to adopt other roles, including a bioenergetic role in neuronal mitochondria. NAA and ATP metabolism appear to be linked indirectly, whereby acetylation of aspartate may facilitate its removal from neuronal mitochondria, thus favoring conversion of glutamate to alpha ketoglutarate which can enter the tricarboxylic acid cycle for energy production. In its role as a mechanism for enhancing mitochondrial energy production from glutamate, NAA is in a key position to act as a magnetic resonance spectroscopy marker for neuronal health, viability and number. Evidence suggests that NAA is a direct precursor for the enzymatic synthesis of the neuron specific dipeptide N-acetylaspartylglutamate, the most concentrated neuropeptide in the human brain. Other proposed roles for NAA include neuronal osmoregulation and axon-glial signaling. We propose that NAA may also be involved in brain nitrogen balance. Further research will be required to more fully understand the biochemical functions served by NAA in CNS development and activity, and additional functions are likely to be discovered.
Keywords: NAA, Canavan disease, myelination, dysmyelination, lipid synthesis, aspartoacylase, energy metabolism, N-acetyl-L-aspartic acid, acetate, acetyl coenzyme A
PubMed ID and Record
N-Acetylaspartate in the CNS: From Neurodiagnostics to Neurobiology
John R. Moffett,1,2 Brian Ross,3 Peethambaran Arun,1 Chikkathur N. Madhavarao,1 and M. A. A. Namboodiri1
1 Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Building C, 4301 Jones Bridge Rd., Bethesda, MD 20814, USA
3 Magnetic Resonance Unit, Huntington Medical Research Institutes, Pasadena, CA; Rudi Schulte Research Institute, Santa Barbara CA and NARSAD
2 Contact: J.R. Moffett, phone (301) 295-9357, fax (301) 295-3566, Email: jmoffett@usuhs.mil.
AbstractThe brain is unique among organs in many respects, including its mechanisms of lipid synthesis and energy production. The nervous system-specific metabolite N-acetylaspartate (NAA), which is synthesized from aspartate and acetyl-coenzyme A in neurons, appears to be a key link in these distinct biochemical features of CNS metabolism. During early postnatal CNS development, the expression of lipogenic enzymes in oligodendrocytes, including the NAA-degrading enzyme aspartoacylase (ASPA), is increased along with increased NAA production in neurons. NAA is transported from neurons to the cytoplasm of oligodendrocytes, where ASPA cleaves the acetate moiety for use in fatty acid and steroid synthesis. The fatty acids and steroids produced then go on to be used as building blocks for myelin lipid synthesis. Mutations in the gene for ASPA result in the fatal leukodystrophy Canavan disease, for which there is currently no effective treatment. Once postnatal myelination is completed, NAA may continue to be involved in myelin lipid turnover in adults, but it also appears to adopt other roles, including a bioenergetic role in neuronal mitochondria. NAA and ATP metabolism appear to be linked indirectly, whereby acetylation of aspartate may facilitate its removal from neuronal mitochondria, thus favoring conversion of glutamate to alpha ketoglutarate which can enter the tricarboxylic acid cycle for energy production. In its role as a mechanism for enhancing mitochondrial energy production from glutamate, NAA is in a key position to act as a magnetic resonance spectroscopy marker for neuronal health, viability and number. Evidence suggests that NAA is a direct precursor for the enzymatic synthesis of the neuron specific dipeptide N-acetylaspartylglutamate, the most concentrated neuropeptide in the human brain. Other proposed roles for NAA include neuronal osmoregulation and axon-glial signaling. We propose that NAA may also be involved in brain nitrogen balance. Further research will be required to more fully understand the biochemical functions served by NAA in CNS development and activity, and additional functions are likely to be discovered.
Keywords: NAA, Canavan disease, myelination, dysmyelination, lipid synthesis, aspartoacylase, energy metabolism, N-acetyl-L-aspartic acid, acetate, acetyl coenzyme A
PubMed ID and Record
posted by Shawna Cullen @ 3:07 AM
0 Comments:
Post a Comment
<< Home